New platform hopes to solve strategic misalignment in biopharma
Nearly three out of five biopharma professionals (58%) believe their company’s potential is restricted by rigidity in daily strategic decision-making. Research commissioned by Nmblr revealed that strategic misalignment is endemic across the industry, threatening both speed to market and the ability to adapt in real-time. … Read More